Skip to content
Open access

Development and External Validation of an M2 Macrophage–Related Prognostic Signature in Breast Cancer Using Multi-Omics Data and Machine Learning

Oct 2026 · Breast Cancer · Vol 18, pp. 1-18 · 0 citations · 38 references
Medicine

TL;DR

A 16-gene M2 macrophage–related signature (M2MMS) was identified that stratified patients into subgroups with distinct survival outcomes in both cohorts and provides a basis for risk stratification and mechanistic investigation.

Abstract

Purpose Tumor-associated macrophages (TAMs), particularly the M2-like phenotype, are central regulators of breast cancer progression; however, clinically applicable models capturing their functional heterogeneity and biological mechanisms remain limited. Patients and Methods We integrated single-cell RNA sequencing, spatial transcriptomics, and bulk RNA-seq data to construct an M2 macrophage–centered gene landscape. A machine learning framework based on 10-fold cross-validation was used to develop a prognostic signature in the TCGA-BRCA cohort (training set), with external validation in the independent GSE96058 cohort. Immune infiltration, genomic instability, pathway activity, and cell–cell communication were analyzed. KLF4 was examined in breast cancer cells and macrophages using qRT-PCR, Western blotting, siRNA-mediated knockdown, and a Transwell co-culture system. Results We identified a 16-gene M2 macrophage–related signature (M2MMS) that stratified patients into subgroups with distinct survival outcomes in both cohorts. High-risk tumors showed M2 macrophage enrichment, an immunosuppressive microenvironment, elevated genomic instability, and activation of E2F and MYC proliferative programs. Cell–cell communication analysis identified MDK–NCL as a dominant tumor–TME signaling axis. KLF4 was upregulated in breast cancer cells and in macrophages after co-culture, and silencing KLF4 attenuated CD206 induction, indicating that KLF4 is functionally involved in tumor cell–induced M2-like polarization in vitro. Conclusion The M2MMS links M2 macrophage–driven immune remodeling to breast cancer prognosis and provides a basis for risk stratification and mechanistic investigation. KLF4 represents a regulatory node in tumor–macrophage interaction in vitro; its role in vivo and the clinical utility of the M2MMS require further validation.

Read PDF

Similar papers

Open access Sep 2026

Dual molecular and clinical machine-learning prognostic modeling in pancreatic ductal adenocarcinoma: a chaperone-mediated autophagy–based framework integrating multi-cohort molecular signatures and a single-center clinical nomogram

This study identified CMA-related cellular heterogeneity, established a molecular prognostic model that retained prognostic discrimination in two independent validation cohorts, demonstrated the functional relevance of KRT19, and developed an independent clinical prediction tool.

Qing-Yan Kou, Sheng-Qian Qiao, Zhen-Yuan Liu et al. · 0 citations
Open access Oct 2026

Machine learning–derived intracellular protein–based prognostic model reflecting a senescence-associated secretory phenotype-driven immunosuppressive microenvironment in lung adenocarcinoma

It is suggested that SASP-related gene-expression patterns are associated with LUAD molecular subtypes, senescence signaling, computationally inferred immune features, and treatment-related outcomes and may serve as a potential biomarker for prognostic stratification in LUAD.

Xiao-Ning Chang, Li-Hong Jiang, Ling-Xiao Zhang et al. · 0 citations
Open access Oct 2026

Integrated Transcriptomic and Single-Cell Analyses Identify a T Cell-Mediated Tumor Killing Gene Signature for Prognostic Stratification and Immune Characterization in Breast Cancer

Background T cell-mediated tumor killing (TTK) is a central mechanism for antitumor immunity. However, the prognostic value of genes regulating TTK sensitivity (GSTTKs) in breast cancer (BC), along with their impact on the immune microenvironment and T-cell dynamics, remains to be systematically elucidated. Methods Usi...

Yu-Hao Zhu, Yi-Yun Chen, Jun-Dong Wu · 0 citations
Open access Sep 2026

Integrated single-cell and bulk tissue analyses reveal distinct macrophage subtypes and a candidate prognostic signature in colorectal cancer: implications for tumor immune characterization

Introduction Colorectal cancer (CRC) represents a major global health burden, marked by high morbidity and mortality rates that place a considerable strain on healthcare systems. Methods This study leveraged integrated bioinformatic analyses, single-cell RNA sequencing, and clinical sample validation to investigate the...

Hui Chen, Zhi-Peng Li, Zhen Lin et al. · 0 citations
Open access Oct 2026

Cross-Cancer Transcriptomic Analysis and Experimental Validation of MDSC-Associated Cell-Cycle Hub Genes as Potential Biomarkers in Breast, Liver, and Lung Cancers

Background/Objectives: Myeloid-derived suppressor cells (MDSCs) play an essential role in tumor immune evasion from the immune system; however, the common molecular signatures associated with MDSCs across different cancer types remain limited. This study aimed to identify and validate common MDSC-associated hub genes a...

Maysa M. Abosenna, Ahmed Osman, Ahmed M. R. Fath El-Bab et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.